Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000104

EVP, Chief Scientific Officer sold 85,089 shares at an average $82.93 ($7,056,216)

  • EVP, Chief Scientific Officer acquired 65,089 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BENNETT C FRANK EVP, Chief Scientific Officer 2026-02-02 Sale 10b5-1 −20,000 $82.60 $1,651,980 80,293 D: show line 1 in the form
BENNETT C FRANK EVP, Chief Scientific Officer 2026-02-02 Option exercise 10b5-1 +48,626 $60.89 $2,960,837 128,919 D: show line 2 in the form
BENNETT C FRANK EVP, Chief Scientific Officer 2026-02-02 Sale 10b5-1 −48,626 $83.03 $4,037,339 80,293 D: show line 3 in the form
BENNETT C FRANK EVP, Chief Scientific Officer 2026-02-02 Option exercise 10b5-1 +16,463 $32.60 $536,694 96,756 D: show line 4 in the form
BENNETT C FRANK EVP, Chief Scientific Officer 2026-02-02 Sale 10b5-1 −16,463 $83.03 $1,366,897 80,293 D: show line 5 in the form
Open-market sales · 85,089 sh · avg $82.93 · $7,056,216

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BENNETT C FRANK EVP, Chief Scientific Officer 2026-02-02 Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −16,463 2,406 D: show line 6 in the form
BENNETT C FRANK EVP, Chief Scientific Officer 2026-02-02 Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −48,626 0 D: show line 7 in the form
Loading xslF345X05/edgardoc.xml…